REQUEST A DEMO
Total
USD $0.00
Search more companies

Lymelab Pharma Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: All Other Miscellaneous Crop Farming | Pharmaceutical Preparation Manufacturing | Department Stores | Electronic Shopping and Mail-Order Houses | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Miscellaneous Schools and Instruction
Full name: Lymelab Pharma Sp. z o.o. Profile Updated: May 03, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Lymelab Pharma Sp. z o.o. is based in Poland, with the head office in Warsaw. The company operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. The company was established on November 25, 2020.

Headquarters
Ul. Jana Kochanowskiego 49A
Warsaw; Mazowieckie; Postal Code: 01-864

Contact Details: Purchase the Lymelab Pharma Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Lymelab Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Lymelab Pharma Sp. z o.o. report to view the information.
Incorporation Date:
November 25, 2020
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
70%
Purchase this report to view the information.
30%
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
No results were found for this company.

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?